FDA-cleared profile

Denti.AI Detect

Denti.AI Technology, Inc. · X-ray/Radiography · FDA-cleared (510(k))

Second-reader dental X-ray software that highlights potential tooth findings and helps measure bone levels for dentist review.

Clinical role
Second-reader CADe detection/highlighting plus post-processing bone-level measurement support.
Images and patients
X-ray/Radiography · Teeth and dental/maxillofacial structures
Key limitation
The cleared scope is limited to the labeled adult dental images and does not replace a complete clinical review or judgment.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?It highlights possible caries and periapical radiolucencies, and helps measure bone levels, while a dentist or dental specialist reviews the radiograph.
  • Which images and patients are in scope?It supports extraoral and intraoral 2D dental radiographs, including bitewing, periapical, and panoramic images, for patients aged 22 years or older without remaining primary teeth.
  • Who uses it?Dental professionals, including dentists and dental specialists, use the output as second-reader support during dental radiograph interpretation.
  • What does the software produce?It produces highlighted regions and per-tooth bone-level measurements, with PDF and DICOM secondary-capture reporting described in the FDA comparison.
  • What is its most important limitation?It is an adjunct, not a replacement for complete clinician review, clinical judgment, patient history, or other relevant information.

Clinical takeaway. Denti.AI Detect adds second-reader highlights and bone-level measurement support for labeled adult dental radiographs; the dental professional remains responsible for the interpretation and care decision.

Evidence takeaway. The FDA package reports separate standalone, bone-measurement, and reader-study endpoints. A 24-reader study reported aided wAFROC 0.809 versus 0.784 unaided; this reader-study result is distinct from the standalone detection and bone-measurement endpoints.

Additional limitations
  • The FDA material describes cloud-based image processing and PDF or DICOM result return, but it does not establish current PACS compatibility, security controls, hosting boundaries, training, pricing, or reimbursement.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Second-reader CADe support for detecting/highlighting caries and periapical radiolucency and for measuring mesial and distal bone levels on extraoral and intraoral 2D dental radiographs in adults aged 22 years and older without remaining primary dentition.
  • Exact FDA submission
  • Checked 2026-09-09
Workflow role
Second-reader CADe detection/highlighting plus post-processing bone-level measurement support.
  • Exact FDA submission
  • Checked 2026-09-09
Required input
Extraoral and intraoral 2D dental radiographs, including bitewing, periapical, and panoramic images, from patients aged 22 years and older without remaining primary dentition; listed formats include JPEG, JPG, TIFF, TIF, PNG, BMP, and DICOM.
  • Exact FDA submission
  • Checked 2026-09-09
Output and clinician action
Highlighted ROIs for caries and periapical radiolucency and mesial/distal bone-level measurements for each tooth, with DICOM secondary-capture/PDF reporting described in the device comparison.
  • Exact FDA submission
  • Checked 2026-09-09
Care setting
Dental radiograph interpretation by dental professionals; the FDA packet does not specify a narrower facility type.
  • Exact FDA submission
  • Checked 2026-09-09
Intended users
Dental professionals, comprising dentists and dental specialists.
  • Exact FDA submission
  • Checked 2026-09-09
Limitations
The device is an adjunct and does not replace complete clinician review or clinical judgment using the image, patient history, and other relevant information; use is limited to patients aged 22 years and older without remaining primary dentition. The periapical CEJ-Bone specificity acceptance criterion was the one listed exception in the bone-measurement study.
  • Exact FDA submission
  • Checked 2026-09-09
Evidence summary
FDA packet: stand-alone caries/periapical-radiolucency testing used 709 images from 6 U.S. sites with three independent dentists and achieved across-category wAFROC AUC 0.737 (95% CI 0.713-0.761) against a prespecified 0.6 lower-bound threshold. Bone-measurement testing used 193 images from 9 U.S. sites with three independent dentists: bitewing CEJ-Bone sensitivity/specificity 98.1%/93.0%, periapical CEJ-Bone 98.2%/88.5%, periapical CEJ-Root 96.9%/92.2%, and extraoral CEJ-Bone-Root 91.6%/84.3%, with task-specific MAEs. A 24-reader, 154-image MRMC study reported aided wAFROC 0.809 versus unaided 0.784 (difference 0.025, p=0.029).
  • Exact FDA submission
  • Checked 2026-09-09

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
FDA packet: stand-alone caries/periapical-radiolucency testing used 709 images from 6 U.S. sites with three independent dentists and achieved across-category wAFROC AUC 0.737 (95% CI 0.713-0.761) against a prespecified 0.6 lower-bound threshold. Bone-measurement testing used 193 images from 9 U.S. sites with three independent dentists: bitewing CEJ-Bone sensitivity/specificity 98.1%/93.0%, periapical CEJ-Bone 98.2%/88.5%, periapical CEJ-Root 96.9%/92.2%, and extraoral CEJ-Bone-Root 91.6%/84.3%, with task-specific MAEs. A 24-reader, 154-image MRMC study reported aided wAFROC 0.809 versus unaided 0.784 (difference 0.025, p=0.029).
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Reported sensitivity
Bone-measurement endpoints: bitewing CEJ-Bone 98.1% (95% CI 96.0%-99.5%); periapical CEJ-Bone 98.2% (96.2%-99.7%); periapical CEJ-Root 96.9% (94.2%-99.0%); extraoral CEJ-Bone-Root 91.6% (89.6%-93.6%).
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09

These are separately labeled bone-measurement endpoints; the caries/periapical stand-alone detection result is wAFROC AUC, and MAE/reader-study endpoints remain distinct.

Reported specificity
Bone-measurement endpoints: bitewing CEJ-Bone 93.0% (95% CI 88.7%-96.7%); periapical CEJ-Bone 88.5% (82.8%-93.4%); periapical CEJ-Root 92.2% (87.9%-96.0%); extraoral CEJ-Bone-Root 84.3% (70.8%-95.8%).
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09

These are separately labeled bone-measurement endpoints; they are not overall CADe detection specificity.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

Denti.AI Detect regulatory performance study summary

  • DesignStand-alone performance and reader study (ACR AI Central category)
  • PopulationAdult
  • Scopeexact submission
  • Tested versionExact product version not reported; regulatory study summarized for FDA submission K230144
  • Samplen=902
  • Sites15
  • IndependenceIndependence not established

K230144

ACR AI Central summarizes the regulatory study; consult the exact FDA materials before comparative use.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The exact-identifier FDA recall query returned no native recall record for K230144. This limited result does not establish absence of recalls or other safety information and does not cover later versions, family records, MAUDE reports, corrections, or field notices.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-09
Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Extraoral and intraoral 2D dental radiographs, including bitewing, periapical, and panoramic images, from patients aged 22 years and older without remaining primary dentition; listed formats include JPEG, JPG, TIFF, TIF, PNG, BMP, and DICOM.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-09 · FDA K230144: Denti.AI Detect

  2. Routing

    Source context, not route validation: The FDA packet describes a cloud-based software-only device accepting the listed image formats and returning a PDF report and DICOM secondary capture to PACS; exact PACS interface versions and local compatibility are not established.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-09 · FDA K230144: Denti.AI Detect

  3. AI processing

    Source context, not route validation: The exact FDA package describes the Denti.AI Detect platform as cloud-based in the subject-device column of its technological comparison table. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "Platform Cloud-based Windows 7 Cloud-based Imaging Intraoral (bitewing," … "Subject Device Primary Predicate Secondary Predicate Device Device". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA K230144: Denti.AI Detect

  4. Returned objects

    Source context, not route validation: Highlighted ROIs for caries and periapical radiolucency and mesial/distal bone-level measurements for each tooth, with DICOM secondary-capture/PDF reporting described in the device comparison.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-09 · FDA K230144: Denti.AI Detect

  5. Viewer/worklist/report

    Unresolved route: Highlighted ROIs for caries and periapical radiolucency and mesial/distal bone-level measurements for each tooth, with DICOM secondary-capture/PDF reporting described in the device comparison.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-09 · FDA K230144: Denti.AI Detect

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes the Denti.AI Detect platform as cloud-based in the subject-device column of its technological comparison table. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "Platform Cloud-based Windows 7 Cloud-based Imaging Intraoral (bitewing," … "Subject Device Primary Predicate Secondary Predicate Device Device". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
The FDA packet describes a cloud-based software-only device accepting the listed image formats and returning a PDF report and DICOM secondary capture to PACS; exact PACS interface versions and local compatibility are not established.
  • Exact FDA submission
  • Checked 2026-09-09

Input or output interoperability

DICOM is explicitly referenced in the described input, output, or workflow.

exact submission · checked 2026-09-01

The model card does not establish every supported DICOM object, transfer method, or local interface.

Supported acquisition environment

Scanner manufacturers: All

exact submission · checked 2026-09-01

Confirm currently supported software versions, protocols, and site-specific acquisition configurations.

ACR exact-submission catalog context

ACR AI Central provides an exact-submission model card for Denti.AI Detect; FDA labeling remains controlling for clinical use, limitations, and performance.

exact submission · checked 2026-09-09
Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K230144
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
X-ray/Radiography
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Anatomy
Teeth and dental/maxillofacial structures
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-09
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-10-06
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-09Last searched
25Fields reviewed
9Source classes checked
0Awaiting review PubMed leads
0Awaiting review trial leads
0Unreviewed FDA recall leads

Exact-submission ACR model-card fields were normalized under the current provenance rules; vendor and independent-study confirmation remain distinct. Exact FDA scope controls clinical claims. ACR provides bounded exact-submission catalog context. Candidate literature metadata remains a discovery queue until full-text identity, endpoint, population, and version review is completed. Automated exact-name discovery found 0 PubMed and 0 ClinicalTrials.gov candidate records. Candidates require human product and version matching; zero candidates is not evidence that no studies exist. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads remain unpublished until a human confirms the exact product and tested version.

Source classes: fda ai list, fda decision summary, acr ai central product, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-09 - Exact FDA submission

    No public price or quote for the exact K230144 configuration was established in this review.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-09-09 - Exact FDA submission

    No exact-product payer policy, coding instruction, or payment determination was established; eligibility must be evaluated by payer, site of service, and use case.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-09 - Exact FDA submission

    Exact-release security controls, data retention, hosting boundaries, and scoped assurance documentation require vendor confirmation.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-09 - Exact FDA submission

    Current training prerequisites, competency checks, and support commitments for the exact configuration require vendor confirmation.

  • Monitoring: Not verified - checked 2026-09-09 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA K230144: Denti.AI Detect

    U.S. Food and Drug Administration - Published 2023-10-06 - Accessed 2026-09-09

    Scope: identity, clinicalUse, modality, anatomy, workflow, evidence, implementation, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Denti.AI Detect model card (K230144)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, careSetting, output, limitations, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. openFDA exact recall query for K230144

    U.S. Food and Drug Administration - Accessed 2026-09-09

    Scope: postmarketSafety

Research history

  1. K230144 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252953

Velmeni for Dentists (V4D) Endo-Perio

Velmeni, Inc.

Authorized purpose: Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth in patients 15 years or older.

Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
Decision
2026-05-11
FDA-cleared K251934

qXR-Detect

Qure.Ai Technologies

Authorized purpose: qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura, mediastinum/hila/heart, bone, hardware and other categories; trained clinicians remain responsible for primary interpretation.

Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions
Decision
2026-01-16
FDA-cleared K242437

Smile Dx®

Cube Click, Inc.

Authorized purpose: Aids dentists reviewing bitewing and periapical radiographs of permanent teeth by detecting/segmenting caries and periapical radiolucencies, identifying restorations and dental anatomy, and measuring mesial/distal bone levels; it does not replace dentist review.

Modality
X-ray/Radiography
Anatomy
Dental/Maxillofacial
Decision
2025-05-14
FDA-cleared K242171

TechCare Trauma

Milvue

Authorized purpose: Aids clinicians and radiologists reviewing 2D X-ray radiographs by detecting, localizing, and characterizing fractures across the FDA-listed appendicular, hip/pelvis, clavicle, and thorax/rib examinations, and by detecting elbow joint effusion on lateral elbow or forearm views in children/adolescents and adults; results are not standalone clinical decisions.

Modality
X-ray/Radiography
Anatomy
MSK
Decision
2025-01-17

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history